How Many Isoforms Must an Alternative Splicing Study Cover?

As many as the claim requires, and the claim should name them before the experiment starts.

The Short Answer

There is no universal number. The requirement is set by the claim:

  • • "Exon X inclusion changes" → quantify that exon's junctions; typically two isoforms.
  • • "Isoform switching occurs" → quantify all annotated isoforms of the gene; typically three to ten, sometimes more.
  • • "A novel isoform is functional" → full-length evidence (long reads) plus protein-level support for that isoform.

Studies that quantify one junction and claim isoform switching are the most common source of over-interpretation in the field.

Coverage Needed for Reliable Calls

MeasurementMinimum for reliability
Junction counts per eventEnough reads for a stable PSI estimate; report counts, not only PSI
Replicates≥3 biological replicates for differential splicing
Total depthDepends on expression of the gene; low-expressed genes need targeted enrichment
Long readsEnough full-length coverage to observe the isoform directly, not infer it

A practical rule: if a PSI estimate is based on fewer than ~20 junction-spanning reads per sample, treat it as provisional and confirm with a targeted assay.

Deciding Which Isoforms Matter

Not every annotated isoform is worth covering. Prioritize by:

  1. Protein consequence — isoforms that change domains, reading frame, or localization.
  2. Expression evidence — isoforms supported by junction data in your cell type, not only by annotation.
  3. Conservation — conserved isoform structures are more likely functional.
  4. NMD susceptibility — isoforms targeted for decay behave differently from stable ones.
  5. Disease annotation — known pathogenic isoform ratios for the gene.

Documenting this prioritization takes one paragraph and pre-empts "why did you ignore isoform 4?".

Reporting Standards

ElementWhat to report
Isoforms quantifiedNames, structures, and evidence for their existence
MethodShort-read, targeted amplicon, or long-read; versions
CoverageJunction counts or full-length reads per isoform
StatisticsTest used, multiple-testing correction
ProteinIsoform-resolved evidence, or an explicit statement that none was obtained
Annotation versionBecause isoform sets change between annotations

The last row matters more than it appears: a claim of "novel isoform" against one annotation may be a known isoform in another.

When Long Reads Are Necessary

  • • The gene has more than a few isoforms and short reads cannot phase junctions.
  • • The claim concerns a novel junction combination.
  • • The isoforms differ only by distant exons.
  • • The study concerns isoform-specific function.

For simple exon-inclusion questions, targeted amplicons remain the most economical reliable method.

Need isoform-resolved validation?

EDITGENE builds splicing models with targeted amplicon and long-read confirmation, endogenous regulatory-site mutations, and isoform-specific protein readouts where antibodies allow.

Tell us the gene and the splicing event. Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Isoform annotation and quantification depend on annotation version, sequencing depth, and algorithm; the number of isoforms reported for a gene varies accordingly.

An inclusion-ratio change is not equivalent to isoform switching, and neither establishes a protein-level consequence without isoform-resolved evidence.

Selected references for further reading

  • • Trapnell C, et al. Transcript assembly and quantification by RNA-seq. Nature Biotechnology. 2010;28:511–515.
  • • Ule J, Blencowe BJ. Alternative splicing regulatory networks. Molecular Cell. 2019;76:329–345.
  • • Wright CJ, et al. Long-read sequencing reveals extended isoform diversity. Nature Reviews Genetics. 2022;23:1–18.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: